GLPG2737, a CFTR Inhibitor, Prevents Cyst Growth in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease.

Saved in:
Bibliographic Details
Title: GLPG2737, a CFTR Inhibitor, Prevents Cyst Growth in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease.
Authors: Dumont V; Translational Science, Galapagos SASU, Romainville, France., Meurisse S; In Vivo Pharmacology, Galapagos SASU, Romainville, France., Verdonck K; Kidney Therapeutic Area Group, Galapagos NV, Mechelen, Belgium., Salgues V; Translational Science, Galapagos SASU, Romainville, France., Robert T; Histology, Galapagos SASU, Romainville, France., Anquetil F; Histology, Galapagos SASU, Romainville, France., Delachaume C; In Vivo Pharmacology, Galapagos SASU, Romainville, France., Blanqué R; Translational Science, Galapagos SASU, Romainville, France., Liekens D; Kidney Therapeutic Area Group, Galapagos NV, Mechelen, Belgium., Huang Y; Mayo Translational Polycystic Kidney Disease Center, Mayo Clinic, Rochester, Minnesota, USA.; Department of Biochemistry and Molecular Biology, School of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Hu J; Mayo Translational Polycystic Kidney Disease Center, Mayo Clinic, Rochester, Minnesota, USA.; Department of Biochemistry and Molecular Biology, School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Division of Nephrology and Hypertension, School of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Harris PC; Mayo Translational Polycystic Kidney Disease Center, Mayo Clinic, Rochester, Minnesota, USA.; Department of Biochemistry and Molecular Biology, School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Division of Nephrology and Hypertension, School of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Nakhlé J; Translational Research, Galapagos SASU, Romainville, France., Conrath K; Target and Pathway Modulation, Galapagos NV, Mechelen, Belgium., Vandeghinste N; Kidney Therapeutic Area Group, Galapagos NV, Mechelen, Belgium, nick.vandeghinste@glpg.com., Christophe T; Therapeutic Area, Galapagos NV, Mechelen, Belgium, thierry.christophe@calliditas.com., Comas D; In Vivo Pharmacology, Galapagos SASU, Romainville, France, dcomas@novalix.com.
Source: American journal of nephrology [Am J Nephrol] 2025; Vol. 56 (6), pp. 802-811. Date of Electronic Publication: 2025 Apr 29.
Publication Type: Journal Article
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 8109361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9670 (Electronic) Linking ISSN: 02508095 NLM ISO Abbreviation: Am J Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1421-9670
DOI:10.1159/000545614